GlobeNewswire by notified

Program for the publication of Yara International ASA fourth quarter results 2021

Share

The Yara International ASA fourth quarter 2021 results will be published on Tuesday8 February2022at08:00 CET.


An on-line presentation will be held at 12:00 CET, hosted by Yara President and CEO Svein Tore Holsether. The presentation will be held in English.

The report, presentation and webcast will be available at the above mentioned times at:
yara.com/investor-relations/latest-quarterly-report/

There will also be a conference call at 13:00 CET the same day with an opportunity to ask questions to Yara’s management.

Please use this link for online registration for the conference call:
http://emea.directeventreg.com/registration/3677663

  • Participants must register in advance of the conference using the link provided. Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and unique registrant ID.
  • In the 10 minutes prior to call start time, you will need to use the conference access information provided in the email received at the point of registering.
  • Note: Due to regional restrictions some participants may receive operator assistance when joining this conference call and will not be automatically connected.

A replay of the conference call will be available from 8 February 18:30 CET until 1 March 18:30 CET. Please use the Dial-in Numbers listed below and Conference ID 3677663:
Norway:         21034235
UK FreeCall:  08082380667
USA:              1(917)677-7532
International: 44(0)3333009785


Yours faithfully
for Yara International ASA

Silje Ingeberg Nygaard
Head of Investor Relations


About Yara

Yara grows knowledge to responsibly feed the world and protect the planet. Supporting our vision of a world without hunger and a planet respected, we pursue a strategy of sustainable value growth, promoting climate-friendly crop nutrition and zero-emission energy solutions. Yara’s ambition is focused on growing a climate positive food future that creates value for our customers, shareholders and society at large and delivers a more sustainable food value chain.

To achieve our ambition, we have taken the lead in developing digital farming tools for precision farming, and work closely with partners throughout the food value chain to improve the efficiency and sustainability of food production. Through our focus on clean ammonia production, we aim to enable the hydrogen economy, driving a green transition of shipping, fertilizer production and other energy intensive industries.

Founded in 1905 to solve the emerging famine in Europe, Yara has established a unique position as the industry’s only global crop nutrition company. We operate an integrated business model with around 17,000 employees and operations in over 60 countries, with a proven track record of strong returns. In 2020, Yara reported revenues of USD 11.6 billion.

www.yara.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Maha Energy: Borrningen av Tie-5 slutförd efter att 240 meter produktiv reservoar genomborrats28.5.2022 23:30:00 CEST | Pressemelding

Maha Energy AB (publ) ("Maha" eller "Bolaget") meddelar att horisontal-borrningen av Tie-5 i Brasilien nu är klar. Slutligt djup för sex tums hålet nåddes den 3 maj och ett 4-1/2 tums produktionsrör har nu sänkts ner och säkrats i brunnen. Längden på horisontalhålet reducerades i slutskedet på grund av försämrade borrhålsförhållanden. Totalt penetrerades 240 meter av produktiv Agua Grande (AG) reservoar med hjälp av nedsänkta elektriska loggningsverktyg. Den horisontella sektionen kommer nu att stimuleras och saneras innan den sätts i produktion. Borrningen av Tie-5 nådde ett djup om 2 548 meter den 3 maj 2022. Totalt har 240 meter (netto) av AG-sand exponerats och ett 4-1/2 tums perforerat produktionsrör har nu sänkts och säkrats i hålet. Det kan jämföras med 14 meter (netto) AG-reservoar som exponerades i den vertikala brunnen Tie-4. Innan Tie-5 sätts i produktion kommer brunnen att genomgå en rad stimulerings- och saneringsoperationer för att rensa horisontalhålet från borrslam. Jon

Maha Energy: Tie-5 reaches Total Depth (TD) with 240 m of net reservoir penetrated28.5.2022 23:30:00 CEST | Press release

Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce that drilling of the Tie-5 horizontal production well is now complete. TD of the 6-1/8” horizontal hole was reached on 3 May and a 4-1/2” completion liner has now been run. The length of the horizontal leg was reduced due to deteriorating hole conditions. A total of 240 m. of net Agua Grande (AG) sand has been logged using measurement while drilling tools and the horizontal section will now be stimulated and cleaned up before being placed on production. Drilling of the Tie-5 horizontal production reached a measured depth of 2,548 m on 3 May, 2022. A total of 240 m of net AG sand has been drilled and a 4-1/2” pre-perforated production liner has now been run in the hole. The exposed length of sand in Tie-5 should be compared with the 14 m. of net sand penetrated in Tie-4. Prior to the well being placed on production, the well will undergo a series of stimulation and clean out operations to enhance production. Jonas Li

FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed28.5.2022 12:01:09 CEST | Press release

FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed Frontline Ltd. (“Frontline” or the "Company") (NYSE: FRO – OSE: FRO) announces that it has agreed to acquire a total of 5,955,705 shares in Euronav N.V. (NYSE: EURN & Euronext: EURN) (“Euronav”) representing 2.95% of the outstanding shares in privately negotiated share exchange transactions with certain shareholders of Euronav N.V. where such shareholders of Euronav N.V. receive consideration shares in Frontline. Frontline will issue a total of 8,337,986 new shares as a result of these transactions, equivalent to an exchange ratio of 1.4. Frontline will be entitled to the declared USD 0,06 dividend to be paid by Euronav on the acquired shares on 8 June 2022. Settlement is expected to take place on or about 1 June 2022 by delivery of existing shares through a share lending arrangement with Frontline's main shareholder Hemen Holding Ltd. Following completion of the issue of the new Frontline shares, F

FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma28.5.2022 00:58:29 CEST | Press release

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1 Sustained clinical benefit from Kymriah treatment demonstrated – of patients who achieved a complete response, 85% were still in response at 12 months1 Kymriah can be administered in the outpatient setting, offering increased flexibility and potentially reducing the burden of therapy for patients and their care teams1,2 Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings1 Basel, May 28, 2022 — Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after two or more lines of systemic therapy. In accordance with the Accelerated Approval Program, continued approval for this indicati

ObsEva Announces Corporate Updates27.5.2022 22:01:00 CEST | Press release

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland– May 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced today that it has entered into a waiver and amendment agreement (Amendment Agreement) with respect to its amended and restated securities purchase agreement (Securities Purchase Agreement) with certain funds and accounts managed by JGB Management, Inc. (JGB), which is structured to provide up to $135 million in borrowing capacity, available in nine tranches. The third tranche under the Securities Purchase Agreement was due to be funded on May 25, 2022. However, the tranche has not been funded as a result of ObsEva not meeting the funding condition that its volume-weighted average share price would not trade below $3.00 per share for five or more trading days during the 30 days prior to the funding date for the third tranche. Pursuant to the Am